相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic value of O-6-methylguanine-DNA methyltransferase (MGMT) protein expression in glioblastoma excluding nontumour cells from the analysis
R. H. Dahlrot et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2018)
Inhibition of NF-kappa B results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression
Zhiyun Yu et al.
CANCER LETTERS (2018)
FM19G11 inhibits O6-methylguanine DNA-methyltransferase expression under both hypoxic and normoxic conditions
Chao-guo You et al.
CANCER MEDICINE (2018)
Primary brain tumours in adults
Sarah Lapointe et al.
LANCET (2018)
Pja2 Inhibits Wnt/β-catenin Signaling by Reducing the Level of TCF/LEF1
Yonghee Song et al.
INTERNATIONAL JOURNAL OF STEM CELLS (2018)
The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling
Peng Han et al.
MOLECULAR CANCER (2017)
Tanshinone IIA induces apoptosis via inhibition of Wnt/β-catenin/MGMT signaling in AtT-20 cells
Zong-Yang Li et al.
MOLECULAR MEDICINE REPORTS (2017)
Pharmacokinetics of Single Ascending Doses and Multiple Doses of 20(S)-Ginsenoside Rg3 in Chinese Healthy Volunteers
Qian Zhao et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2016)
Sulforaphane reverses chemo-resistance to temozolomide in glioblastoma cells by NF-κB-dependent pathway downregulating MGMT expression
Fengming Lan et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Chemoproteomics-Enabled Discovery of a Potent and Selective Inhibitor of the DNA Repair Protein MGMT
Chao Wang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Pygo2 activates MDR1 expression and mediates chemoresistance in breast cancer via the Wnt/β-catenin pathway
Z-M Zhang et al.
ONCOGENE (2016)
Glioma Stem Cells: Signaling, Microenvironment, and Therapy
Brandon D. Liebelt et al.
STEM CELLS INTERNATIONAL (2016)
Wnt Signaling in Cancer Stem Cell Biology
Felipe de Sousa e Melo et al.
CANCERS (2016)
Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance
Malin Wickstrom et al.
NATURE COMMUNICATIONS (2015)
High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
R. Stupp et al.
ANNALS OF ONCOLOGY (2014)
Stereoselectiye Skin Anti-photoaging Properties of Ginsenoside Rg3 in UV-B-Irradiated Keratinocytes
Chang-Jin Lim et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2014)
MGMT testing-the challenges for biomarker-based glioma treatment
Wolfgang Wick et al.
NATURE REVIEWS NEUROLOGY (2014)
Stereospecific anticancer effects of ginsenoside Rg3 epimers isolated from heat-processed American ginseng on human gastric cancer cell
Eun-Hwa Park et al.
JOURNAL OF GINSENG RESEARCH (2014)
Sensitization of TRAIL-Induced Cell Death by 20(S)-Ginsenoside Rg3 via CHOP-Mediated DR5 Upregulation in Human Hepatocellular Carcinoma Cells
Ju-Yeon Lee et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Stereoisomers ginsenosides-20(S)-Rg3 and-20(R)-Rg3 differentially induce angiogenesis through peroxisome proliferator-activated receptor-gamma
Hoi-Hin Kwok et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Toxicity of a novel anti-tumor agent 20(S)-ginsenoside Rg3: A 26-week intramuscular repeated administration study in rats
J. -P. Liu et al.
FOOD AND CHEMICAL TOXICOLOGY (2012)
Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights
Kimberly Ng et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
STAT3 Inhibition Overcomes Temozolomide Resistance in Glioblastoma by Downregulating MGMT Expression
Shinji Kohsaka et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Balancing repair and tolerance of DNA damage caused by alkylating agents
Dragony Fu et al.
NATURE REVIEWS CANCER (2012)
Towards personalized therapy for patients with glioblastoma
Katsuyuki Shirai et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2011)
Toxicity of a novel anti-tumor agent 20(S)-ginsenoside Rg3: A 26-week intramuscular repeated administration study in Beagle dogs
J. -P. Liu et al.
FOOD AND CHEMICAL TOXICOLOGY (2011)
Effects of Panax ginseng on Tumor Necrosis Factor-α-Mediated Inflammation: A Mini-Review
Davy C. W. Lee et al.
MOLECULES (2011)
Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide
K. A. van Nifterik et al.
BRITISH JOURNAL OF CANCER (2010)
Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United States
Stuart A. Grossman et al.
CLINICAL CANCER RESEARCH (2010)
MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
Michael Weller et al.
NATURE REVIEWS NEUROLOGY (2010)
O-6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients
Sabine Spiegl-Kreinecker et al.
NEURO-ONCOLOGY (2010)
Sensitivity to temozolomide in brain tumor initiating cells
Michael D. Blough et al.
NEURO-ONCOLOGY (2010)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Current Evaluation of the Millennium Phytomedicine- Ginseng (II): Collected Chemical Entities, Modern Pharmacology, and Clinical Applications Emanated from Traditional Chinese Medicine
Lee Jia et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts
Gaspar J. Kitange et al.
NEURO-ONCOLOGY (2009)
The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/β-catenin pathway
M. Flahaut et al.
ONCOGENE (2009)
20(S)-ginsenoside Rg3 enhances glucose-stimulated insulin secretion and activates AMPK
Min Woo Park et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2008)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
M Esteller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
